These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

564 related items for PubMed ID: 21118333

  • 1. Elective surgery in patients with congenital coagulopathies and inhibitors: experience of the National Haemophilia Centre of Venezuela.
    Boadas A, Fernández-Palazzi F, De Bosch NB, Cedeño M, Ruiz-Sáez A.
    Haemophilia; 2011 May; 17(3):422-7. PubMed ID: 21118333
    [Abstract] [Full Text] [Related]

  • 2. Elective orthopaedic surgery for haemophilia patients with inhibitors: single centre experience of 40 procedures and review of the literature.
    Caviglia H, Candela M, Galatro G, Neme D, Moretti N, Bianco RP.
    Haemophilia; 2011 Nov; 17(6):910-9. PubMed ID: 21342367
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Consensus protocol for the use of recombinant activated factor VII [eptacog alfa (activated); NovoSeven] in elective orthopaedic surgery in haemophilic patients with inhibitors.
    Giangrande PL, Wilde JT, Madan B, Ludlam CA, Tuddenham EG, Goddard NJ, Dolan G, Ingerslev J.
    Haemophilia; 2009 Mar; 15(2):501-8. PubMed ID: 19187194
    [Abstract] [Full Text] [Related]

  • 6. Recombinant activated factor VII for haemophilia patients with inhibitors undergoing orthopaedic surgery: a review of the literature.
    Obergfell A, Auvinen MK, Mathew P.
    Haemophilia; 2008 Mar; 14(2):233-41. PubMed ID: 18081827
    [Abstract] [Full Text] [Related]

  • 7. Relationship between factor VII activity and clinical efficacy of recombinant factor VIIa given by continuous infusion to patients with factor VIII inhibitors.
    Santagostino E, Morfini M, Rocino A, Baudo F, Scaraggi FA, Gringeri A.
    Thromb Haemost; 2001 Oct; 86(4):954-8. PubMed ID: 11686352
    [Abstract] [Full Text] [Related]

  • 8. Surgical experience with rFVIIa (NovoSeven) in congenital haemophilia A and B patients with inhibitors to factors VIII or IX.
    Valentino LA, Cooper DL, Goldstein B.
    Haemophilia; 2011 Jul; 17(4):579-89. PubMed ID: 21294815
    [Abstract] [Full Text] [Related]

  • 9. Prospective, randomised trial of two doses of rFVIIa (NovoSeven) in haemophilia patients with inhibitors undergoing surgery.
    Shapiro AD, Gilchrist GS, Hoots WK, Cooper HA, Gastineau DA.
    Thromb Haemost; 1998 Nov; 80(5):773-8. PubMed ID: 9843170
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. U.S. survey of surgical capabilities and experience with surgical procedures in patients with congenital haemophilia with inhibitors.
    Shapiro A, Cooper DL.
    Haemophilia; 2012 May; 18(3):400-5. PubMed ID: 22168829
    [Abstract] [Full Text] [Related]

  • 15. Ten-year experience of recombinant activated factor VII use in surgical patients with congenital haemophilia with inhibitors or acquired haemophilia in Japan.
    Takedani H, Shima M, Horikoshi Y, Koyama T, Fukutake K, Kuwahara M, Ishiguro N.
    Haemophilia; 2015 May; 21(3):374-379. PubMed ID: 25521821
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.